European phase III pivotal trial investigating the efficacy of voclosporin for the prevention of renal transplant rejection.

Trial Profile

European phase III pivotal trial investigating the efficacy of voclosporin for the prevention of renal transplant rejection.

Planning
Phase of Trial: Phase III

Latest Information Update: 10 Nov 2011

At a glance

  • Drugs Voclosporin (Primary) ; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 10 Nov 2011 Isotechnika receives positive Scientific Advice from the EMA for this trial.
    • 02 Nov 2011 New trial record
    • 18 Oct 2011 Isotechnika receives positive Scientific Advice from the EMA for its proposed protocol, according to a Isotechnika Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top